title: Functional and clinical aspects of the myelomonocyte protein calprotectin.
authors.affiliation: Nycomed Pharma AS, Oslo, Norway. berit.johne@nycomed.telemax.no
authors.forename: B
authors.initials: B
authors.lastname: Johne
authors.forename: M K
authors.initials: MK
authors.lastname: Fagerhol
authors.forename: T
authors.initials: T
authors.lastname: Lyberg
authors.forename: H
authors.initials: H
authors.lastname: Prydz
authors.forename: P
authors.initials: P
authors.lastname: Brandtzaeg
authors.forename: C F
authors.initials: CF
authors.lastname: Naess-Andresen
authors.forename: I
authors.initials: I
authors.lastname: Dale
mesh_terms: D000935:Antifungal Agents / Q000097:blood* / Q000737:chemistry; D015415:Biomarkers / Q000097:blood; D001826:Body Fluids / Q000737:chemistry; D002135:Calcium-Binding Proteins / Q000097:blood / Q000737:chemistry / Q000502:physiology*; D005767:Gastrointestinal Diseases / Q000175:diagnosis; D006801:Humans; D039841:Leukocyte L1 Antigen Complex; D009000:Monocytes / Q000378:metabolism; D019006:Neural Cell Adhesion Molecules / Q000097:blood / Q000737:chemistry / Q000502:physiology*; D012216:Rheumatic Diseases / Q000175:diagnosis*
chemical_list: D000935:Antifungal Agents; D015415:Biomarkers; D002135:Calcium-Binding Proteins; D039841:Leukocyte L1 Antigen Complex; D019006:Neural Cell Adhesion Molecules